Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ science, today announced the formal launch of the first drug candidate of NAD Pharmaceuticals Corp., its wholly owned subsidiary ...

Angela’s progress reflects the broader purpose of cancer rehabilitation at Levine Cancer: helping patients manage the ...

Researchers have uncovered a molecular “switch” that helps explain why exercise keeps ageing muscles healthy. By reducing ...

The report highlights how common data standards can improve interoperability, trip coordination and rider access for rural, ...

The EU Anti-Corruption Directive has familiar foundations. What’s different is its mandated compliance framework and ...

The Missouri Bootheel consistently ranks in the bottom of most health measures in the state, and it struggles to attract and ...

Babies born in the U.S. between July 2 and Dec. 31, 2026, will receive a "first-of-its-kind" commemorative Social Security card.

Vanta reports four risk treatment strategies-mitigate, accept, transfer, and avoid-to effectively manage threats, enhancing ...

A UK model finds a surprising top modifiable risk factor; patient and staff satisfaction with the model of care is high.

Two strong opinions collided, but neither told the whole story.

United Therapeutics, a biotechnology company with co-headquarters and manufacturing facilities in Research Triangle Park, has acquired a Boston-area biotech company to boost its efforts in ...

Oxford life sciences company MitoRx has opened a lab on the Babraham Research Campus in Cambridge as an additional ...